Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Kushihata

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Clinical Nephrology|October 17, 1998
Effect of H2-blockers on serum calcium and phosphorus in hemodialysis patients on calcium carbonate therapyS Kushihata, N Yorioka
The International Journal of Artificial Organs|September 24, 1998
Effects of dialysis membranes on the kinetics of tumor necrosis factor-alpha production by peripheral mononuclear cells in chronic hemodialysis patientsS Kushihata, N Yorioka, H Oda, et al.
Kidney International. Supplement|July 21, 1999
Apolipoprotein E polymorphism and renal diseaseH Oda, N Yorioka, C Ueda, et al.
Nephron|January 1, 1995
Glomerulocystic kidney disease in a young adultN Yorioka, T Ogawa, H Oda, et al.
Nephron|January 1, 1996
Nicardipine hydrochloride suppresses DNA synthesis in human mesangial cells stimulated with recombinant human (rh) platelet-derived growth factor AA, rh interleukin-1 alpha, or rh tumor necrosis factor-alphaH Oda, N Yorioka, T Ito, et al.
The International Journal of Artificial Organs|May 6, 1998
CAPD catheter rupture without deteriorationS Kushihata, N Yorioka, T Ito, et al.
The International Journal of Artificial Organs|April 29, 1998
Fatal hepatic failure caused by miliary tuberculosis in a hemodialysis patient: case reportS Kushihata, N Yorioka, Y Nishida, et al.
Nephron|January 1, 1996
Hepatocyte growth factor localization in primary glomerulonephritis and drug-induced interstitial nephritisY Taniguchi, N Yorioka, K Yamashita, et al.
Nephron|January 1, 1997
Remnant-like particle cholesterol may indicate atherogenic risk in patients on chronic hemodialysisH Oda, N Yorioka, S Okushin, et al.
The Journal of International Medical Research|May 29, 1998
Dose escalation induces tolerance to side-effects of erythropoietin in a patient with dialysis anaemia: case reportN Ohira, K Takasugi, N Takasugi, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Clinical Nephrology|October 17, 1998
Effect of H2-blockers on serum calcium and phosphorus in hemodialysis patients on calcium carbonate therapyS Kushihata, N Yorioka
The International Journal of Artificial Organs|September 24, 1998
Effects of dialysis membranes on the kinetics of tumor necrosis factor-alpha production by peripheral mononuclear cells in chronic hemodialysis patientsS Kushihata, N Yorioka, H Oda, et al.
Kidney International. Supplement|July 21, 1999
Apolipoprotein E polymorphism and renal diseaseH Oda, N Yorioka, C Ueda, et al.
Nephron|January 1, 1995
Glomerulocystic kidney disease in a young adultN Yorioka, T Ogawa, H Oda, et al.
Nephron|January 1, 1996
Nicardipine hydrochloride suppresses DNA synthesis in human mesangial cells stimulated with recombinant human (rh) platelet-derived growth factor AA, rh interleukin-1 alpha, or rh tumor necrosis factor-alphaH Oda, N Yorioka, T Ito, et al.
The International Journal of Artificial Organs|May 6, 1998
CAPD catheter rupture without deteriorationS Kushihata, N Yorioka, T Ito, et al.
The International Journal of Artificial Organs|April 29, 1998
Fatal hepatic failure caused by miliary tuberculosis in a hemodialysis patient: case reportS Kushihata, N Yorioka, Y Nishida, et al.
Nephron|January 1, 1996
Hepatocyte growth factor localization in primary glomerulonephritis and drug-induced interstitial nephritisY Taniguchi, N Yorioka, K Yamashita, et al.
Nephron|January 1, 1997
Remnant-like particle cholesterol may indicate atherogenic risk in patients on chronic hemodialysisH Oda, N Yorioka, S Okushin, et al.
The Journal of International Medical Research|May 29, 1998
Dose escalation induces tolerance to side-effects of erythropoietin in a patient with dialysis anaemia: case reportN Ohira, K Takasugi, N Takasugi, et al.
Pageof 2